Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shortened intravenous NAC regimen for paracetamol overdose
ACTRN12619001549112Phase 3Recruiting
- Sponsor
- Monash Health
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of acetylcysteine in acetaminophen poisoning (2 arms), sponsored by Monash Health. Primary endpoint: Absolute difference in ALT from admission to 20 hours. Started Dec 2019; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
acetaminophen poisoning
Beyond the preview
Go deeper on ACTRN12619001549112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001549112.